K+S (ETR:SDF) Full Year 2022 Results
Key Financial Results
- Revenue: €5.68b (up 77% from FY 2021).
- Net income: €1.51b (down 31% from FY 2021).
- Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses.
- EPS: €7.88 (down from €11.35 in FY 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
K+S EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%.
Looking ahead, revenue is expected to decline by 7.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.0%.
Performance of the German Chemicals industry.
The company's shares are down 6.4% from a week ago.
Risk Analysis
Before you take the next step you should know about the 3 warning signs for K+S (1 is a bit unpleasant!) that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if K+S might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.